| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/27/2007 | CN1985815A Local medicine preparation containing antiinfective medicine composition and its preparing method |
| 06/27/2007 | CN1985812A Lung-targeting florfenicol microsphere for animal and birds and its preparing method |
| 06/27/2007 | CN1985811A Preparing process of hypericin injection |
| 06/27/2007 | CN1985810A Slow control released methylphenidate hydrochloride capsule and its preparing method |
| 06/27/2007 | CN1985808A Carbazochrome sodium sulfonate slow-released tablet and its preparing method |
| 06/27/2007 | CN1985807A Compound Desloratadine-Ambroxol oral disintegrated tablet and its preparing method |
| 06/27/2007 | CN1985806A Oral dissolved Brufen tablet and its preparing method |
| 06/27/2007 | CN1985805A Lung targeting clarithromycin microsphere for animal and birds and its preparing method |
| 06/27/2007 | CN1985804A Glutathione based delivery system |
| 06/27/2007 | CN1985803A Aerosol combination |
| 06/27/2007 | CN1985802A Cnidiadin emulsion and its preparing method and application |
| 06/26/2007 | US7236820 Standardized swallow challenge medium and method of use for esophageal function testing |
| 06/26/2007 | US7235639 Reaction product with nucleic acid crosslinking agent such as psoralen; intercalate between base pairs of nucleic acids in material to be decontaminated and on ex vivo exposure to ultraviolet light; enhances oxygen carrying capacity of blood in subjects with bacterial, viral, or retroviral infections |
| 06/26/2007 | US7235627 Derivatives of GLP-1 analogs |
| 06/26/2007 | US7235585 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 06/26/2007 | US7235536 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prophylaxis of fungal infection |
| 06/26/2007 | US7235535 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 06/26/2007 | US7235522 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 06/26/2007 | US7235391 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 06/26/2007 | US7235260 Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor |
| 06/26/2007 | US7235259 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 06/26/2007 | US7235253 Stabilization by adding to the aqueous liquid at least one compound selected from the group consisting of a nonionic surfactant, a water-soluble, nonionic, organic binder, hydrogenated lecithin, and mannitol. |
| 06/26/2007 | US7235248 Pharmaceutical compositions comprising cyclosporins |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | US7235240 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents |
| 06/26/2007 | CA2494473C Stabilized protein compositions for topical administration and methods of making same |
| 06/26/2007 | CA2455231C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/26/2007 | CA2455137C Antiperspirant compositions containing film-forming polymers |
| 06/26/2007 | CA2402791C Pre-formed sheet devices for topical application comprising a benefit agent coated solid gel sheet |
| 06/26/2007 | CA2379605C Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 06/22/2007 | CA2571276A1 Modified release formulation of lithium carbonate and method for the preparation thereof |
| 06/21/2007 | WO2007070799A1 Method for deriving a wellness related index for a food composition |
| 06/21/2007 | WO2007070454A2 High protein supplement |
| 06/21/2007 | WO2007070269A1 Release agent composition for skin adhesives |
| 06/21/2007 | WO2007070135A1 Compounds |
| 06/21/2007 | WO2007069895A1 Annexin derivatives suitable for pretargeting in therapy and diagnosis |
| 06/21/2007 | WO2007069709A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 06/21/2007 | WO2007069675A1 Easily absorbed oral preparation containing xanthine derivative |
| 06/21/2007 | WO2007069662A1 Adhesive preparation |
| 06/21/2007 | WO2007069661A1 Bisoprolol-containing adhesive patch |
| 06/21/2007 | WO2007069378A1 Drug package |
| 06/21/2007 | WO2007069358A1 Novel preparation of gastric retention type |
| 06/21/2007 | WO2007069068A2 Cell penetrating peptide conjugates for delivering nucleic acids into cells |
| 06/21/2007 | WO2007068963A2 Therapeutic compositions comprising ingenol-3-angelate |
| 06/21/2007 | WO2007068906A2 Production of conjugates |
| 06/21/2007 | WO2007068747A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 06/21/2007 | WO2007068718A1 Polypeptide protracting tags |
| 06/21/2007 | WO2007068701A1 Aqueous-alcoholic depigmenting gel |
| 06/21/2007 | WO2007068492A1 Medicinal composition with active ingredients and wound contact layer with a composition |
| 06/21/2007 | WO2007068491A1 Medicinal composition and wound contact layer comprising a composition |
| 06/21/2007 | WO2007068490A1 Antimicrobial wound contact layer |
| 06/21/2007 | WO2007068443A1 Powder compositions for inhalation |
| 06/21/2007 | WO2007068212A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 06/21/2007 | WO2007036278A8 Method for stabilising pharmaceutical administration forms that contain micro-organisms |
| 06/21/2007 | WO2007027421A3 Method for diagnosing non-small cell lung carcinoma |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | US20070142442 Stabilized pharmaceutical compositions containing a calcium channel blocker |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142344 fluocinonide or fluocinonide acetonide topical with two or more penetration enhancers |
| 06/21/2007 | US20070142343 Mixture with penetration intensifiers, solvents and emulsifiers |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/21/2007 | US20070142324 Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070142267 Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 06/21/2007 | US20070141620 Producing polyoxyethylene glycol covalently bound to human interferon; antiinflammatory and antitumor agents; autoimmune diseases and infections; conjugation decreases the number of doses for an intended effect, simplify and stabilize the formulation of a composition |
| 06/21/2007 | US20070141162 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 06/21/2007 | US20070141158 Amphiphilic heparin derivative formed by coupling a heparin with a bile acid |
| 06/21/2007 | US20070141153 Orally administered pharmaceutical composition |
| 06/21/2007 | US20070141149 Controlled-release pharmaceutical formulation |
| 06/21/2007 | US20070141142 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| 06/21/2007 | US20070141141 Pharmaceutical composition |
| 06/21/2007 | US20070141139 Composition for intestinal delivery |
| 06/21/2007 | US20070141137 Stable capsule preparation |
| 06/21/2007 | US20070141124 Induced-viscosity nutritional emulsions |
| 06/21/2007 | US20070141123 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/21/2007 | US20070141122 Nutritional composition and method of manufacture |
| 06/21/2007 | US20070141121 Method of treating kidney disease |
| 06/21/2007 | US20070141120 Peptide having an ace inhibiting effect |
| 06/21/2007 | US20070141119 Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values |
| 06/21/2007 | US20070141109 Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury |
| 06/21/2007 | US20070141096 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 06/21/2007 | US20070141086 Use of antibiotics as vaccine adjuvants |
| 06/21/2007 | US20070141078 Monovalent; low dose of egg-derived influenza virus antigen from an influenza virus strain associated with or having the potential to cause a pandemic outbreak (e.g. H5N1antigen), with an oil in water emulsion adjuvant of an oil, alpha-tocopherol, and an emulsifier; can be made quickly in pandemic |
| 06/21/2007 | US20070141077 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 06/21/2007 | US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 06/21/2007 | US20070141025 Compositions and methods for cancer immunotherapy |
| 06/21/2007 | US20070141022 Polymeric delivery agents and delivery agent compounds |
| 06/21/2007 | US20070141014 Formulation assistants |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | US20070140981 Intranasal compositions |
| 06/21/2007 | US20070140975 Opioid formulations having reduced potential for abuse |
| 06/21/2007 | US20070140972 Targeting compositions and preparation therof |
| 06/21/2007 | DE102005051334A1 Preparation, useful e.g. as a hardening agent and catalyst, and in cosmetics and medicines, comprises a low-molecular substance and a hyperbranched polymer having a hydrophilic core containing polyester unit and hydrophobic terminal group |
| 06/21/2007 | CA2636139A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 06/21/2007 | CA2634073A1 Compositions comprising ingenol-3-angelate |
| 06/21/2007 | CA2633372A1 Easily absorbed oral preparations of xanthine derivatives |
| 06/21/2007 | CA2633125A1 Adhesive pharmaceutical preparation containing bisoprolol |